Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amogh Count Up Syrup is an Ayurvedic herbal formulation developed and marketed by Amogh Pharmaceuticals. It is categorized as a 'Blood/Platelet Supporter' and is primarily used as a supportive treatment to help increase platelet counts in patients suffering from thrombocytopenia, a condition frequently associated with viral infections such as Dengue and Malaria. The formulation typically leverages the therapeutic properties of traditional Indian herbs, most notably Carica papaya (Papaya) leaf extract and Tinospora cordifolia (Giloy), which are recognized in Ayurvedic practice for their ability to stimulate thrombopoiesis and enhance immune function. As a consumer health product, it is available through e-commerce platforms and is classified as a nutraceutical or herbal supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Amogh Count Up Syrup.